CORY FREEDLAND, PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Neurogene Inc.

Filing Date Source Excerpt
2024-04-26 "Prior to transitioning to life sciences finance, Dr. Freedland worked as a research scientist for Roche... Dr. Freedland received his Ph.D. in Pharmacology"

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-14